This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morita, Y.
Right arrow Articles by Poole, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morita, Y.
Right arrow Articles by Poole, K.

 Previous Article  |  Next Article 

Journal of Bacteriology, December 2006, p. 8649-8654, Vol. 188, No. 24
0021-9193/06/$08.00+0     doi:10.1128/JB.01342-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

nalD Encodes a Second Repressor of the mexAB-oprM Multidrug Efflux Operon of Pseudomonas aeruginosa{triangledown}

Yuji Morita,1 Lily Cao,1 Virginia C. Gould,2 Matthew B. Avison,2 and Keith Poole1*

Department of Microbiology & Immunology, Queen's University, Kingston, ON, Canada K7L 3N6,1 Bristol Centre for Antimicrobial Research and Evaluation, Department of Pathology & Microbiology, University of Bristol, School of Medical Sciences, University Walk, Bristol, BS8 1TD United Kingdom2

Received 23 August 2006/ Accepted 28 September 2006


arrow
ABSTRACT
 
The Pseudomonas aeruginosa nalD gene encodes a TetR family repressor with homology to the SmeT and TtgR repressors of the smeDEF and ttgABC multidrug efflux systems of Stenotrophomonas maltophilia and Pseudomonas putida, respectively. A sequence upstream of mexAB-oprM and overlapping a second promoter for this efflux system was very similar to the SmeT and TtgR operator sequences, and NalD binding to this region was, in fact, demonstrated. Moreover, increased expression from this promoter was seen in a nalD mutant, consistent with NalD directly controlling mexAB-oprM expression from a second promoter.


arrow
TEXT
 
Pseudomonas aeruginosa is an opportunistic human pathogen that demonstrates an innate resistance to multiple classes of antimicrobials (5), a property explained in part by the operation of multidrug efflux systems of the resistance-nodulation division (RND) family (19, 20). Several RND-type multidrug efflux systems have been described in P. aeruginosa (20), although the major system contributing to intrinsic multidrug resistance is encoded by the mexAB-oprM operon (4, 10, 21). MexAB-OprM exports a variety of clinically used antimicrobials (including several classes of antibiotics and biocides) (19, 20) but, as well, several additional agents with antimicrobial activity (e.g., dyes [9], detergents [34], and organic solvents such as aromatic hydrocarbons [11]) and acylhomoserine lactones (AHLs) associated with quorum sensing (3, 18). AHLs play a role in cell density-dependent expression of a number of virulence factors in P. aeruginosa and, thus, the activity of this efflux system can influence virulence (6). The observation that MexAB-OprM overproduction can compromise bacterial "fitness" (29) and that pump-overproducing mutants of P. aeruginosa can be selected in animal models of infection in the absence of antimicrobial selection (7) also point to in vivo functions for this pump independent of antimicrobial efflux and resistance.

Hyperproduction of MexAB-OprM has been documented in so-called nalB mutants (13) carrying lesions in the mexR gene (13, 26, 35, 38) encoding a repressor of mexAB-oprM expression (22, 35). MexR is a member of the MarR family of regulators (16) and binds as a dimer (12) to two sites in the mexR-mexA intragenic region, near mexR and overlapping promoters for mexR and mexAB-oprM (2). MexAB-OprM hyperexpression also occurs independently of mutations in mexR; these so-called nalC mutants (1, 13, 35) carry a mutation in a gene (PA3721, also known as nalC) that encodes a TetR family repressor of an adjacent two-gene operon, PA3720-PA3719 (1). It is, in fact, the increased expression of PA3719 that results from disruption of the nalC repressor gene that promotes mexAB-oprM hyperexpression (1), apparently as a result of PA3719 modulation of MexR repressor activity (L. Cao, S. Fraud, D. Daigle, M. Wilke, A. Pacey, C. Dean, N. Strynadka, and K. Poole, submitted for publication). Recently, mutations in yet a third gene, nalD, also encoding a TetR family repressor-like protein, have been described that are responsible for mexAB-oprM hyperexpression in multidrug-resistant P. aeruginosa (32). We show here that NalD binds to a second promoter upstream of mexAB-oprM, consistent with it directly repressing efflux gene expression, and nalD mutations thus affording multidrug resistance via derepression of mexAB-oprM.

Disruption of the nalD gene (PA3574) was shown previously to increase mexAB-oprM expression and multidrug resistance, consistent with NalD functioning to negatively regulate expression of this efflux system (32). Consistent with this, too, introduction of the nalD gene (on plasmid pMLS003 [Table 1 ]) into P. aeruginosa strain K870 (22) reduced resistance to representative MexAB-OprM antimicrobial substrates, including carbenicillin (MIC reduced from 64 to 32 µg/ml) and chloramphenicol (MIC reduced from 32 to 8 µg/ml). Interestingly, the nalD gene product shows substantial similarity to the SmeT (28) and TtgR (37) repressors of the smeDEF and ttgABC RND-type multidrug efflux operons of Stenotrophomonas maltophilia and Pseudomonas putida, respectively (SmeT, 34% identity; TtgR, 36% identity), with sequence conservation being highest in the first 55 amino acids of the proteins (Fig. 1A). SmeT, TtgR, and NalD are members of the TetR family of regulatory proteins that typically bind target DNA through a prototypical N-terminal helix-turn-helix (HTH) domain (23) and, indeed, such a domain is predicted to occur at the same place within the N termini of each of these proteins (Fig. 1A). Moreover, the predicted HTH motifs of these proteins are highly similar (13 of 21 HTH residues are exact matches in all three proteins [Fig. 1A]), suggesting that they may recognize the same or related nucleotide sequences in their respective target DNAs. TtgR and SmeT have been shown to bind upstream of their respective target efflux operons, with a TtgR-binding site precisely defined and shown to encompass canonical –35/–10 ttgABC promoter sequences (37) (Fig. 1B). Although an actual binding SmeT site has not been delineated, a binding site has been proposed that similarly overlaps the smeDEF promoter region (28) (Fig. 1B). Intriguingly, the TtgR- and SmeT-binding sequences are very similar (Fig. 1B), and a related sequence was identified upstream of the mexAB-oprM operon (23/30 matches with the TtgR- and SmeT-binding sequences) (Fig. 1B). Moreover, this sequence overlaps a putative second promoter for mexAB-oprM (PII) (Fig. 1B) downstream (i.e., more mexAB-oprM proximal) from the primary mexAB-oprM promoter (PI) (Fig. 1B) identified previously and shown to be regulated by the MexR repressor (2). This earlier study also provided evidence for mexAB-oprM expression from a second, more mexAB-oprM-proximal promoter, and a second set of canonical –35 and –10 sequences was identified closer to mexAB-oprM, although an exact transcription start site was not identified (2).


View this table:
[in this window]
[in a new window]

  		TABLE 1. Bacterial strains and plasmids


Figure 1
View larger version (25K):
[in this window]
[in a new window]

  		FIG. 1. Identification of a putative DNA-binding motif in NalD (A) and a putative NalD-binding site upstream of mexAB-oprM (B) that impacts mexAB-oprM expression (C). (A) Multiple sequence alignment of NalD and the SmeT (GenBank accession number CAC87048) and TtgR (GenBank accession number AAK15050) repressors performed online using ClustalW (http://www.ebi.ac.uk/clustalw/). Exact matches (*) and conserved changes (:) are indicated. Putative DNA-binding helix-turn-helix regions were identified using the online Motif HTH program (http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page = npsa_hth.html) available from the Pôle Bioinformatique Lyonnais website (http://pbil.univ-lyon1.fr/) and are highlighted in boldface italics. (B) Nucleotide sequence of the mexR-mexA intergenic region. Canonical –35/–10 regions for a confirmed mexAB-oprM-distal (–35 [I]/–10 [I]; PI) and a putative mexAB-oprM-proximal (–35 [II]/–10 [II]; PII) promoter are highlighted in italicized boldface text. The translational start sites for mexR and mexA are indicated (underlined in boldface text), as are two MexR-binding sites (boxed sequence) overlapping PI. mexA-distal (delineated by open arrowheads) and -proximal (delineated by filled arrowheads) sequences used in electrophoretic mobility shift assays are also indicated. Promoter PI- and PII-containing sequences cloned into the lacZ transcriptional fusion vector pMP190 are delineated with arrows labeled PI and PI-t (for promoter PI) and either PII-1 and PII-t or PII-2 and PII-t (for promoter PII). A transcriptional start site identified downstream of the PII –10 region using RACE (C) is boxed. Sequences from the smeDEF (smeD) and ttgABC (ttgA) promoter regions of S. maltophilia and P. putida, respectively, that encompass putative (smeD) or known (ttgA) binding sites for the cognate repressors SmeT and TtgR are shown below the mexR-mexA intergenic sequence aligned with the putative mexAB-oprM promoter PII (mexA). Exact matches for all three promoter sequences are shown in uppercase text. The site of a mutation (C->T) yielding increased mexAB-oprM expression and multidrug resistance in a previous paper (22) is highlighted by an asterisk. (C) 5'-RACE product (lane 1) from pLC66-carrying NalD– P. aeruginosa strain K2543 obtained with a 5'-RACE kit-provided 5'-end primer (20-mer) and mexA-specific primer annealing 220 bp into mexA. A transcript initiating from PII would yield a product of ca. 320 bp. Lane 2, 100-bp ladder.

One possibility, then, is that NalD functions to regulate mexAB-oprM expression directly, by controlling expression of the efflux genes from this second promoter. Indeed, a previous study (25) noted that a C-T transition mutation within the putative NalD-binding region (Fig. 1B) increased mexAB-oprM expression and antibiotic resistance, as would be expected were this region targeted by NalD. To assess NalD binding to the second mexAB-oprM promoter region, attempts were made to construct and purify a polyhistidine (His)-tagged NalD protein for use in an electrophoretic mobility shift assay (EMSA). A His-tagged version of NalD was engineered by amplification of the nalD gene (also known as PA3574) from plasmid pMLS003 using PCR (17) and cloning it into plasmid pET23a (Novagen, Madison, WI) to yield pLC80 (primers and parameters available upon request). Following introduction of pLC80 into the expression strain Escherichia coli BL21(DE3), NalD-His expression induced with 1 mM isopropyl-ß-D-thiogalactopyranoside (IPTG; in a 5-ml LB culture supplemented with ampicillin) was measured as described before (33). Immunoblotting (33) using anti-His antibodies (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) confirmed NalD-His expression in whole-cell extracts (24) of pLC80-carrying E. coli BL21(DE3), although levels seen were insufficient to warrant attempts at purification. Crude soluble extracts have, however, been employed previously in assessing protein-DNA interactions in mobility shift assays (28) and, so, soluble whole-cell extracts were prepared from log-phase E. coli BL21(DE3) cells carrying pLC80 (25 ml) and induced with IPTG (1 mM) following disruption of cells by sonication (2). Following centrifugation (300,000 x g; 15 min), the NalD-His-containing supernatant was recovered and the protein concentration was determined using the BCA protein assay kit (Pierce, Rockford, IL).

The ca. 200-bp target DNA to be used in gel shift assays, encompassing the promoter PII region upstream of mexA but downstream of the previously identified MexR-binding sites (Fig. 1B), was amplified from the chromosome of P. aeruginosa PAO1 strain K767 (14) using PCR. A control DNA (200 bp) upstream of the PII region and overlapping the MexR-binding region was similarly PCR amplified. The gel shift assay was performed using an EMSA kit (E33075; Molecular Probes, Inc., Invitrogen) according to the manufacturer's instructions. Briefly, 40 ng target DNA was incubated with increasing amounts of NalD-His-containing crude soluble extract (250 ng, 500 ng, and 1,000 ng) for 20 min at room temperature in a 15-µl reaction mixture containing 1x binding buffer (750 mM KCl, 0.5 mM dithiothreitol, 0.5 mM EDTA, 50 mM Tris-HCl, pH 7.4). Following the addition of EMSA gel-loading solution, mixtures were separated by electrophoresis on a nondenaturing 8% (wt/vol) polyacrylamide gel in 0.5x TBE buffer (22 mM Tris-HCl, 22 mM boric acid, 0.5 mM EDTA, pH 8.0) (27), and gels were stained with 1x SYBR Green EMSA nucleic acid stain. DNA was then visualized using digital photography with an S6656 SYPRO photographic filter. As seen in Fig. 2, extracts prepared from E. coli cells expressing NalD-His from pLC80 clearly shifted the mexA-proximal DNA fragment (Fig. 2B, panel I, lanes 2 to 4), while extracts prepared from the control strain carrying the pET23a vector without insert did not (Fig. 2B, panel II, lanes 2 to 4). This is consistent with NalD binding to sequences proximal to mexA. The NalD-containing extract did not, however, shift the mexA-distal fragment that encompasses the PI promoter region (Fig. 2B, panel III, lanes 2 to 4), indicating that NalD binding in the first instance was specific and that NalD directly regulates mexAB-oprM expression. As such, mexAB-oprM hyperexpression in nalD strains is explainable by loss of NalD repression of efflux gene expression.


Figure 2
View larger version (50K):
[in this window]
[in a new window]

  		FIG. 2. NalD expression (A) and binding to sequences upstream of mexAB-oprM (B). (A) Western immunoblot of E. coli BL21(DE3) carrying pET23a (lanes 1 and 2) or pLC80 (pET23a::nalD) (lanes 3 and 4) with (lanes 2 and 4) or without (lanes 1 and 3) IPTG induction developed using an anti-His antibody. (B) Mobility shift assay in which soluble protein extracts (lane 1, 0 ng; lane 2, 250 ng; lane 3, 500 ng; lane 4, 1,000 ng) prepared from E. coli BL21(DE3) cells carrying pLC80 (panels I and III) or pET23a (panel II) were incubated with DNA fragments encompassing the mexA-proximal (panels I and II) or -distal (panel III) portions of the mexR-mexA intergenic region. The mexA-proximal and -distal regions are delineated in Fig. 1B by filled and open arrowheads, respectively.

While NalD clearly binds downstream of MexR to sequences more proximal to mexAB-oprM, it remains a possibility that it simply provides for a second negative regulator of efflux gene expression from the distal and, to date, only confirmed promoter, PI (Fig. 1B), rather than a repressor of expression from a putative second mexAB-oprM promoter, PII. Evidence for a promoter downstream of PI was subsequently sought by fusing this region to a promoterless lacZ gene on plasmid pMP190. The region beginning 60 bp upstream of a putative PII –35 region and ending just before the mexA gene (PII-1) (Fig. 1B) was amplified from the chromosome of P. aeruginosa K767 by PCR and cloned into pMP190, and the resultant PII-lacZ fusion vector (pYM026) was mobilized into wild-type strain K767 and a NalD– derivative, K2543. The latter was constructed following cloning of a nalD::mini-Tn5-tet-containing PstI fragment from the nalD mutant strain K2346 (Table 1) into the gene replacement vector pK18mobsacB and its subsequent introduction into K767 as described previously (1). Neither of the pYM026-containing strains demonstrated more than minimal ß-galactosidase activity (measured using Luria broth-grown log-phase cells as described in reference 15) (data not shown), consistent with little or no promoter activity and in apparent agreement with earlier results (30). Still, when a larger mexA-proximal fragment (extending further upstream to just after the PI –10 region [i.e., PII-2]) (Fig. 1B) was fused to lacZ in pMP190 (yielding pYM030), ß-galactosidase activity was again minimal in NalD+ K767 but was substantially increased (14-fold) in the NalD– K2543 strain (Table 2). In contrast, a PI-lacZ fusion constructed in pMP190 (pYM025) following PCR amplification of the PI region (Fig. 1B) showed substantial activity in wild-type K767, consistent with PI being active in wild-type P. aeruginosa, as highlighted previously (2), and its activity was not markedly changed (1.5-fold increase) in the NalD– mutant (Table 2). As expected, the cloned nalD but not the mexR gene reduced PII-mediated lacZ expression in K2543 (Table 2). These data are consistent with the presence of a mexA-proximal PII promoter that is specifically NalD controlled. Failure to detect this activity in earlier studies (30) likely stems from its weak activity in the wild-type (i.e., NalD+) strain, where it appears to be almost wholly repressed.


View this table:
[in this window]
[in a new window]

  		TABLE 2. Activity of mexAB-oprM PI and PII promoters in P. aeruginosaa

Interestingly, the active NalD-controlled promoter region described above extends well into the second of two MexR-binding sites that overlap PI, where MexR might be expected to bind on the lacZ fusion. Still, a pYM030-carrying {Delta}mexR K767 derivative (K2568) did not show any significant increase in ß-galactosidase activity relative to the MexR+ K767 parent (although PI-lacZ did increase, as expected) (Table 2), indicating that the mexA-proximal promoter is not MexR controlled. In contrast to results with NalD– strain K2543, however, loss of nalD in the MexR– strain only modestly (<4-fold) enhanced PII activity (Table 2, compare K2569 and K2568). Again, PI activity was unaffected by loss of nalD (Table 2). This suggests that the NalD-controlled mexA-proximal promoter is most active in MexR+ cells when MexR is bound to PI (i.e., in vivo when expression from PI is abrogated). Any reduction in PII activity measured with the PII-lacZ-containing pYM030 in MexR– (versus MexR+) cells cannot be due to strong transcription from PI interfering with transcription from PII, since pYM030 lacks PI. One possibility, then, is that a productive PII conformation can only be achieved when MexR is bound to the PI region. Consistent with this, overexpression of the cloned mexR gene (from pLC66) increased the PII activity of pYM030 twofold in NalD– strain K2543 (Table 2).

Given the sequence similarly of the putative PII promoter (Fig. 1B) with the known promoters of smeDEF and ttgABC, including a region implicated in repressor binding in all three instances, it is tempting to suggest it is a de facto second promoter for mexAB-oprM. Still, the fact that a PII promoter activity was observed only when sequence extending ca. >100 bp upstream of the putative PII promoter was engineered into the pMP190 promoter-proving vector suggests that either the indicated PII is not the NalD-controlled promoter for mexAB-oprM expression or that substantial upstream sequence is somehow needed for functional topology/conformation of this promoter. Using 5' rapid amplification of cDNA ends (RACE) analysis as before (2) with mRNA isolated from the NalD– P. aeruginosa strain K2543 carrying the mexR plasmid pLC66 (where maximal PII activity was detectable and expression from PI was repressed [Table 1]), a single cDNA corresponding to the 5' end of a mexAB-oprM-specific mRNA was recovered (Fig. 1C). The size of the cDNA (ca. 300 bp) was consistent with transcription having been initiated from the PII promoter and, indeed, DNA sequencing identified the transcription start site as downstream of the canonical –10 site of the predicted PII promoter (Fig. 1B). Clearly, then, PII is a second, NalD-regulated promoter for mexAB-oprM expression in P. aeruginosa.

Fusion of the entirety of the mexR-mexA intergenic region to lacZ on pMP190 (a PI plus PII-lacZ fusion; pYM031) yielded activities in K767 and K2543 consistent with PI being solely responsible for mexAB-oprM expression in wild-type cells (where PI activity = PI + PII) (Table 2), while both contribute in a NalD– strain. Moreover, the ca. twofold increase in PI plus PII activity (i.e., total mexAB-oprM promoter activity) seen in NalD– strain K2543 (compared with K767 [Table 2]) is in agreement with the known impact of a nalD mutation on mexAB-oprM expression and multidrug resistance (32). In wild-type MexR+ NalD+ cells, then, mexAB-oprM expression can be influenced by both regulators responding to their own particular signals that require or reflect a need for MexAB-OprM efflux activity. Thus, mexAB-oprM expression reflects the integration of multiple signals via two direct regulators, MexR and NalD, although the signals to which these regulators respond remain to be elucidated.


arrow
ACKNOWLEDGMENTS
 
This work was supported by grants from the Canadian Cystic Fibrosis Foundation (to K.P.) and the British Society for Antimicrobial Chemotherapy (to M.B.A. and G.G.). L.C. was supported by an Ontario Graduate Scholarship.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology & Immunology, Queen's University, Kingston, ON, Canada K7L 3N6. Phone: (613) 533-6677. Fax: (613) 533-6796. E-mail: poolek{at}post.queensu.ca. Back

{triangledown} Published ahead of print on 6 October 2006. Back


arrow
REFERENCES
 
    1
  1. Cao, L., R. Srikumar, and K. Poole. 2004. MexAB-OprM hyperexpression in NalC type multidrug resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719. Mol. Microbiol. 53:1423-1436.[CrossRef][Medline]
    2. 2
  2. Evans, K., L. Adewoye, and K. Poole. 2001. MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexA-mexR intergenic region. J. Bacteriol. 183:807-812.[Abstract/Free Full Text]
    3. 3
  3. Evans, K., L. Passador, R. Srikumar, E. Tsang, J. Nezezon, and K. Poole. 1998. Influence of the MexAB-OprM multidrug efflux system on quorum-sensing in Pseudomonas aeruginosa. J. Bacteriol. 180:5443-5447.[Abstract/Free Full Text]
    4. 4
  4. Gotoh, N., H. Tsujimoto, K. Poole, J.-I. Yamagishi, and T. Nishino. 1995. The outer membrane protein OprM of Pseudomonas aeruginosa is encoded by oprK of the mexA-mexB-oprK multidrug resistance operon. Antimicrob. Agents Chemother. 39:2567-2569.[Abstract]
    5. 5
  5. Hancock, R. E. W., and D. P. Speert. 2000. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Res. Update 3:247-255.
    6. 6
  6. Hirakata, Y., R. Srikumar, K. Poole, N. Gotoh, T. Suematsu, S. Kohno, S. Kamihira, R. E. Hancock, and D. P. Speert. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa. J. Exp. Med. 196:109-118.[Abstract/Free Full Text]
    7. 7
  7. Join-Lambert, O. F., M. Michea-Hamzehpour, T. Kohler, F. Chau, F. Faurisson, S. Dautrey, C. Vissuzaine, C. Carbon, and J. C. Pechere. 2001. Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats. Antimicrob. Agents Chemother. 45:571-576.[Abstract/Free Full Text]
    8. 8
  8. Keen, N. T., S. Tamaki, D. Kobayashi, and D. Trollinger. 1988. Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria. Gene 70:191-197.[CrossRef][Medline]
    9. 9
  9. Li, X.-Z., K. Poole, and H. Nikaido. 2003. Contributions of MexAB-OprM and an EmrE homologue to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes. Antimicrob. Agents Chemother. 47:27-33.[Abstract/Free Full Text]
    10. 10
  10. Li, X.-Z., H. Nikaido, and K. Poole. 1995. Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1948-1953.[Abstract]
    11. 11
  11. Li, X.-Z., L. Zhang, and K. Poole. 1998. Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. J. Bacteriol. 180:2987-2991.[Abstract/Free Full Text]
    12. 12
  12. Lim, D., K. Poole, and N. C. Strynadka. 2002. Crystal structure of the MexR repressor from the multidrug efflux operon in Pseudomonas aeruginosa. J. Biol. Chem. 277:29253-29259.[Abstract/Free Full Text]
    13. 13
  13. Llanes, C., D. Hocquet, C. Vogne, D. Benali-Baitich, C. Neuwirth, and P. Plesiat. 2004. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob. Agents Chemother. 48:1797-1802.[Abstract/Free Full Text]
    14. 14
  14. Masuda, N., and S. Ohya. 1992. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:1847-1851.[Abstract/Free Full Text]
    15. 15
  15. Miller, J. H. 1992. A short course in bacterial genetics. A laboratory manual and handbook for Escherichia coli and related bacteria, p. 72-74. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
    16. 16
  16. Miller, P. F., and M. C. Sulavik. 1996. Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Esherichia coli. Mol. Microbiol. 21:441-448.[CrossRef][Medline]
    17. 17
  17. Morita, Y., M. L. Sobel, and K. Poole. 2006. Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene product. J. Bacteriol. 188:1847-1855.[Abstract/Free Full Text]
    18. 18
  18. Pearson, J. P., C. Van Delden, and B. H. Iglewski. 1999. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J. Bacteriol. 181:1203-1210.[Abstract/Free Full Text]
    19. 19
  19. Poole, K. 2004. Efflux-mediated multiresistance in gram-negative bacteria. Clin. Microbiol. Infect. 10:12-26.[Medline]
    20. 20
  20. Poole, K. 2004. Efflux pumps, p. 635-674. In J.-L. Ramos (ed.), Pseudomonas, vol. I, Genomics, life style and molecular architecture. Kluwer Academic/Plenum Publishers, New York, N.Y.
    21. 21
  21. Poole, K., K. Krebes, C. McNally, and S. Neshat. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372.[Abstract/Free Full Text]
    22. 22
  22. Poole, K., K. Tetro, Q. Zhao, S. Neshat, D. Heinrichs, and N. Bianco. 1996. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob. Agents Chemother. 40:2021-2028.[Abstract]
    23. 23
  23. Ramos, J. L., M. Martinez-Bueno, A. J. Molina-Henares, W. Teran, K. Watanabe, X. Zhang, M. T. Gallegos, R. Brennan, and R. Tobes. 2005. The TetR family of transcriptional repressors. Microbiol. Mol. Biol. Rev. 69:326-356.[Abstract/Free Full Text]
    24. 24
  24. Redly, G. A., and K. Poole. 2003. Pyoverdine-mediated regulation of FpvA synthesis in Pseudomonas aeruginosa: involvement of a probable ECF sigma factor, FpvI. J. Bacteriol. 185:1261-1265.[Abstract/Free Full Text]
    25. 25
  25. Saito, K., S. Eda, H. Maseda, and T. Nakae. 2001. Molecular mechanism of MexR-mediated regulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 195:23-28.[Medline]
    26. 26
  26. Saito, K., H. Yoneyama, and T. Nakae. 1999. nalB-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome. FEMS Microbiol. Lett. 179:67-72.[CrossRef][Medline]
    27. 27
  27. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
    28. 28
  28. Sanchez, P., A. Alonso, and J. L. Martinez. 2002. Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. Antimicrob. Agents Chemother. 46:3386-3393.[Abstract/Free Full Text]
    29. 29
  29. Sanchez, P., J. F. Linares, B. Ruiz-Diez, E. Campanario, A. Navas, F. Baquero, and J. L. Martinez. 2002. Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants. J. Antimicrob. Chemother. 50:657-664.[Abstract/Free Full Text]
    30. 30
  30. Sanchez, P., F. Rojo, and J. L. Martinez. 2002. Transcriptional regulation of mexR, the repressor of Pseudomonas aeruginosa mexAB-oprM multidrug efflux pump. FEMS Microbiol. Lett. 207:63-68.[Medline]
    31. 31
  31. Simon, R., U. Priefer, and A. Puehler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram-negative bacteria. Biotechnology 1:784-791.[CrossRef]
    32. 32
  32. Sobel, M. L., D. Hocquet, L. Cao, P. Plesiat, and K. Poole. 2005. Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in lab and clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:1782-1786.[Abstract/Free Full Text]
    33. 33
  33. Srikumar, R., T. Kon, N. Gotoh, and K. Poole. 1998. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob. Agents Chemother. 42:65-71.[Abstract/Free Full Text]
    34. 34
  34. Srikumar, R., X.-Z. Li, and K. Poole. 1997. Inner membrane efflux components are responsible for the ß-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa. J. Bacteriol. 179:7875-7881.[Abstract/Free Full Text]
    35. 35
  35. Srikumar, R., C. J. Paul, and K. Poole. 2000. Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa. J. Bacteriol. 182:1410-1414.[Abstract/Free Full Text]
    36. 36
  36. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60-89.[Medline]
    37. 37
  37. Teran, W., A. Felipe, A. Segura, A. Rojas, J. L. Ramos, and M.-T. Gallegos. 2003. Antibiotic-dependent induction of Pseudomonas putida DOT-T1E TtgABC efflux pump is mediated by the drug binding repressor TtgR. Antimicrob. Agents Chemother. 47:3067-3072.[Abstract/Free Full Text]
    38. 38
  38. Ziha-Zarifi, I., C. Llanes, T. Koehler, J.-C. Pechere, and P. Plesiat. 1999. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob. Agents Chemother. 43:287-291.[Abstract/Free Full Text]

Journal of Bacteriology, December 2006, p. 8649-8654, Vol. 188, No. 24
0021-9193/06/$08.00+0     doi:10.1128/JB.01342-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Lister, P. D., Wolter, D. J., Hanson, N. D. (2009). Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms. Clin. Microbiol. Rev. 22: 582-610 [Abstract] [Full Text]  
  • Wilke, M. S., Heller, M., Creagh, A. L., Haynes, C. A., McIntosh, L. P., Poole, K., Strynadka, N. C. J. (2008). The crystal structure of MexR from Pseudomonas aeruginosa in complex with its antirepressor ArmR. Proc. Natl. Acad. Sci. USA 105: 14832-14837 [Abstract] [Full Text]  
  • Mima, T., Joshi, S., Gomez-Escalada, M., Schweizer, H. P. (2007). Identification and Characterization of TriABC-OpmH, a Triclosan Efflux Pump of Pseudomonas aeruginosa Requiring Two Membrane Fusion Proteins. J. Bacteriol. 189: 7600-7609 [Abstract] [Full Text]  
  • Daigle, D. M., Cao, L., Fraud, S., Wilke, M. S., Pacey, A., Klinoski, R., Strynadka, N. C., Dean, C. R., Poole, K. (2007). Protein Modulator of Multidrug Efflux Gene Expression in Pseudomonas aeruginosa. J. Bacteriol. 189: 5441-5451 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morita, Y.
Right arrow Articles by Poole, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morita, Y.
Right arrow Articles by Poole, K.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»